SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4u0g'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IDW_B_017B401_1 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 11	ALA A 169 ASP A 175 VAL A 178 GLY A 198 ILE A 179	None	1.03A	2idwA-4u0gA: undetectable	2idwA-4u0gA: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_B_017B200_2 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 9	ALA A 169 ASP A 175 VAL A 178 GLY A 198 ILE A 179	None	1.06A	3ektB-4u0gA: undetectable	3ektB-4u0gA: 19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EL4_A_ROCA100_2 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 9	ALA A 169 VAL A 178 GLY A 198 ILE A 199 THR A 183	None	1.16A	3el4B-4u0gA: undetectable	3el4B-4u0gA: 18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM3_B_478B200_2 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 ASP A 175 VAL A 178 GLY A 198 ILE A 179	None	0.98A	3em3B-4u0gA: undetectable	3em3B-4u0gA: 18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXV_C_478C200_2 (HIV-1 PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 11	ALA A 169 ASP A 175 VAL A 178 GLY A 198 ILE A 179	None	0.96A	3oxvD-4u0gA: undetectable	3oxvD-4u0gA: 18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXW_B_017B200_2 (HIV-1 PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 ASP A 175 VAL A 178 GLY A 198 ILE A 179	None	0.98A	3oxwB-4u0gA: undetectable	3oxwB-4u0gA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXW_D_017D200_2 (HIV-1 PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 ASP A 175 VAL A 178 GLY A 198 ILE A 179	None	1.02A	3oxwD-4u0gA: undetectable	3oxwD-4u0gA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DQC_A_017A101_1 (ASPARTYL PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 ASP A 175 VAL A 178 GLY A 198 ILE A 179	None	1.03A	4dqcA-4u0gA: undetectable	4dqcA-4u0gA: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1G_A_LNLA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (Mycobacterium tuberculosis)	5 / 12	ILE H 40 GLY H 100 ALA H 96 SER H 66 GLY H 33	None	0.95A	4e1gA-4u0gH: undetectable	4e1gA-4u0gH: 15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GBO_A_CUA301_0 (E7)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 5	HIS A 171 ALA A 117 GLN A 94 TYR A 90	None	1.19A	4gboA-4u0gA: undetectable	4gboA-4u0gA: 22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MBS_B_MRVB1101_2 (CHIMERA PROTEIN OF C-C CHEMOKINE RECEPTOR TYPE 5 AND RUBREDOXIN)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 5	TYR A 206 LEU A 189 THR A 202 MET A 125	None	1.49A	4mbsB-4u0gA: undetectable	4mbsB-4u0gA: 18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_B_017B101_1 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 11	ALA A 169 VAL A 178 GLY A 198 THR A 183 ILE A 179	None	0.99A	4njtA-4u0gA: undetectable	4njtA-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_D_017D101_1 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 11	ALA A 169 VAL A 178 GLY A 198 THR A 183 ILE A 179	None	0.88A	4njtC-4u0gA: undetectable	4njtC-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_A_TPVA500_2 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 VAL A 178 GLY A 198 ILE A 199 ILE A 179	None	1.08A	4njuB-4u0gA: undetectable	4njuB-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_A_TPVA500_2 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 VAL A 178 GLY A 198 THR A 183 ILE A 179	None	1.05A	4njuB-4u0gA: undetectable	4njuB-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_C_TPVC500_2 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 VAL A 178 GLY A 198 ILE A 199 ILE A 179	None	1.07A	4njuD-4u0gA: undetectable	4njuD-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_C_TPVC500_2 (PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 10	ALA A 169 VAL A 178 GLY A 198 THR A 183 ILE A 179	None	1.05A	4njuD-4u0gA: undetectable	4njuD-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O1Z_B_MXMB807_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 12	MET A 93 LEU A 60 LEU A 115 ALA A 53 SER A 52	None	0.91A	4o1zB-4u0gA: undetectable	4o1zB-4u0gA: 16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWP_A_GCSA303_1 (CHITOSANASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (Mycobacterium tuberculosis)	4 / 6	GLU H 101 TYR H 183 ILE H 165 THR H 158	None	0.92A	4qwpA-4u0gH: undetectable	4qwpA-4u0gH: 23.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWP_B_GCSB302_1 (CHITOSANASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (Mycobacterium tuberculosis)	4 / 5	GLU H 101 TYR H 183 ILE H 165 THR H 158	None	0.88A	4qwpB-4u0gH: undetectable	4qwpB-4u0gH: 23.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RVJ_B_478B101_1 (HIV-1 PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 11	ALA A 169 VAL A 178 GLY A 198 THR A 183 ILE A 179	None	0.97A	4rvjA-4u0gA: undetectable	4rvjA-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RVJ_D_478D101_1 (HIV-1 PROTEASE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 11	ALA A 169 VAL A 178 GLY A 198 THR A 183 ILE A 179	None	0.96A	4rvjC-4u0gA: undetectable	4rvjC-4u0gA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XJ7_D_ADND303_1 (5'/3'-NUCLEOTIDASE SURE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (Mycobacterium tuberculosis)	5 / 10	LEU H 103 LEU H 32 GLY H 100 SER H 98 ALA H 76	None None None ZIL H 301 ( 2.9A) None	1.12A	4xj7C-4u0gH: undetectable 4xj7D-4u0gH: undetectable	4xj7C-4u0gH: 24.07 4xj7D-4u0gH: 24.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTA_G_MFXG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 7	ARG A 180 GLY A 177 THR A 162 GLU A 165	SO4 A 302 (-4.6A) None None None	0.99A	5btaA-4u0gA: undetectable 5btaC-4u0gA: undetectable 5btaD-4u0gA: undetectable	5btaA-4u0gA: 19.78 5btaC-4u0gA: 19.78 5btaD-4u0gA: 23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTA_H_MFXH101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCAC GTAA)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 6	ARG A 180 GLY A 177 THR A 162 GLU A 165	SO4 A 302 (-4.6A) None None None	0.96A	5btaA-4u0gA: undetectable 5btaB-4u0gA: undetectable 5btaC-4u0gA: undetectable	5btaA-4u0gA: 19.78 5btaB-4u0gA: 23.37 5btaC-4u0gA: 19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTC_G_CPFG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 6	ARG A 180 GLY A 177 THR A 162 GLU A 165	SO4 A 302 (-4.6A) None None None	1.01A	5btcA-4u0gA: undetectable 5btcC-4u0gA: undetectable 5btcD-4u0gA: undetectable	5btcA-4u0gA: 19.78 5btcC-4u0gA: 19.78 5btcD-4u0gA: 23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTC_G_CPFG102_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 6	ARG A 180 GLY A 177 THR A 162 GLU A 165	SO4 A 302 (-4.6A) None None None	0.97A	5btcA-4u0gA: undetectable 5btcB-4u0gA: undetectable 5btcC-4u0gA: undetectable	5btcA-4u0gA: 19.78 5btcB-4u0gA: 23.37 5btcC-4u0gA: 19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTF_F_GFNF101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 7	ARG A 180 GLY A 177 THR A 162 GLU A 165	SO4 A 302 (-4.6A) None None None	0.97A	5btfA-4u0gA: undetectable 5btfB-4u0gA: undetectable 5btfC-4u0gA: undetectable	5btfA-4u0gA: 19.78 5btfB-4u0gA: 23.37 5btfC-4u0gA: 19.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_O_BEZO801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 6	PHE A 83 SER A 110 HIS A 135 PRO A 137 MET A 164	ZIL A 301 (-4.5A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 (-3.8A) ZIL A 301 ( 2.9A)	0.49A	5dzka-4u0gA: 27.3 5dzko-4u0gA: undetectable	5dzka-4u0gA: 100.00 5dzko-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_P_BEZP801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 5	SER A 110 ALA A 111 HIS A 135 MET A 164	ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 ( 2.9A)	0.41A	5dzkb-4u0gA: 27.7 5dzkp-4u0gA: undetectable	5dzkb-4u0gA: 100.00 5dzkp-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_P_BEZP801_1 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 6	PHE A 83 SER A 110 ALA A 111 HIS A 135 MET A 164	ZIL A 301 (-4.5A) ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 ( 2.9A)	0.49A	5dzkB-4u0gA: 27.7 5dzkP-4u0gA: undetectable	5dzkB-4u0gA: 100.00 5dzkP-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_Q_BEZQ801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 5	SER A 110 ALA A 111 HIS A 135 MET A 164	ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 ( 2.9A)	0.42A	5dzkc-4u0gA: 27.3 5dzkq-4u0gA: undetectable	5dzkc-4u0gA: 100.00 5dzkq-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_R_BEZR801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	6 / 7	PHE A 83 SER A 110 ALA A 111 HIS A 135 PRO A 137 MET A 164	ZIL A 301 (-4.5A) ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 (-3.8A) ZIL A 301 ( 2.9A)	0.47A	5dzkD-4u0gA: 27.4 5dzkR-4u0gA: undetectable	5dzkD-4u0gA: 100.00 5dzkR-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_R_BEZR801_1 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	6 / 8	PHE A 83 SER A 110 ALA A 111 HIS A 135 PRO A 137 MET A 164	ZIL A 301 (-4.5A) ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 (-3.8A) ZIL A 301 ( 2.9A)	0.47A	5dzkd-4u0gA: 27.4 5dzkr-4u0gA: undetectable	5dzkd-4u0gA: 100.00 5dzkr-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_S_BEZS801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 6	PHE A 83 SER A 110 HIS A 135 MET A 164	ZIL A 301 (-4.5A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 ( 2.9A)	0.50A	5dzke-4u0gA: 27.6 5dzks-4u0gA: undetectable	5dzke-4u0gA: 100.00 5dzks-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_T_BEZT801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 5	SER A 110 ALA A 111 HIS A 135 MET A 164	ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 ( 2.9A)	0.42A	5dzkf-4u0gA: 27.4 5dzkt-4u0gA: undetectable	5dzkf-4u0gA: 100.00 5dzkt-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_T_BEZT801_1 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	6 / 8	PHE A 83 SER A 110 ALA A 111 HIS A 135 PRO A 137 MET A 164	ZIL A 301 (-4.5A) ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 (-3.8A) ZIL A 301 ( 2.9A)	0.46A	5dzkF-4u0gA: 27.4 5dzkT-4u0gA: undetectable	5dzkF-4u0gA: 100.00 5dzkT-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_U_BEZU801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	5 / 6	PHE A 83 SER A 110 ALA A 111 HIS A 135 MET A 164	ZIL A 301 (-4.5A) ZIL A 301 ( 4.0A) ZIL A 301 ( 4.0A) ZIL A 301 (-3.7A) ZIL A 301 ( 2.9A)	0.49A	5dzkg-4u0gA: 27.4 5dzku-4u0gA: undetectable	5dzkg-4u0gA: 100.00 5dzku-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_W_BEZW801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (Mycobacterium tuberculosis; Mycobacterium tuberculosis)	4 / 5	PHE A 147 ILE H 71 GLY H 127 ILE H 146	ZIL H 301 ( 4.8A) ZIL H 301 (-3.6A) ZIL H 301 ( 3.5A) ZIL H 301 ( 3.3A)	0.38A	5dzkB-4u0gA: 27.7 5dzkI-4u0gA: 31.4 5dzkW-4u0gA: undetectable	5dzkB-4u0gA: 100.00 5dzkI-4u0gA: 41.58 5dzkW-4u0gA: 1.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5DZK_Y_BEZY801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (Mycobacterium tuberculosis; Mycobacterium tuberculosis)	4 / 5	PHE A 147 ILE H 71 GLY H 127 ILE H 146	ZIL H 301 ( 4.8A) ZIL H 301 (-3.6A) ZIL H 301 ( 3.5A) ZIL H 301 ( 3.3A)	0.35A	5dzkd-4u0gA: 27.4 5dzkk-4u0gA: 31.4 5dzky-4u0gA: undetectable	5dzkd-4u0gA: 100.00 5dzkk-4u0gA: 41.58 5dzky-4u0gA: 1.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M5K_A_ADNA502_2 (ADENOSYLHOMOCYSTEINA SE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 4	GLN A 136 THR A 183 THR A 167 LEU A 86	None None None ZIL A 301 ( 4.3A)	1.49A	5m5kA-4u0gA: undetectable	5m5kA-4u0gA: 18.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M5K_C_ADNC502_2 (ADENOSYLHOMOCYSTEINA SE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 4	GLN A 136 THR A 183 THR A 167 LEU A 86	None None None ZIL A 301 ( 4.3A)	1.49A	5m5kC-4u0gA: undetectable	5m5kC-4u0gA: 18.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M66_B_ADNB502_2 (ADENOSYLHOMOCYSTEINA SE)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 4	GLN A 136 THR A 183 THR A 167 LEU A 86	None None None ZIL A 301 ( 4.3A)	1.46A	5m66B-4u0gA: undetectable	5m66B-4u0gA: 18.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UIZ_A_CUA301_0 (AA10A)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 5	HIS A 171 ALA A 117 GLN A 94 TYR A 90	None	1.21A	5uizA-4u0gA: undetectable	5uizA-4u0gA: 22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F3M_B_ADNB502_2 (-)	4u0g	ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 (Mycobacterium tuberculosis)	4 / 4	GLN A 136 THR A 183 THR A 167 LEU A 86	None None None ZIL A 301 ( 4.3A)	1.47A	6f3mB-4u0gA: undetectable	6f3mB-4u0gA: 17.83

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2IDW_B_017B401_1","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;ASP A 175;VAL A 178;GLY A 198;ILE A 179","None","1.03A","2idwA-4u0gA:undetectable","2idwA-4u0gA:23.23"],["3EKT_B_017B200_2","PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;ASP A 175;VAL A 178;GLY A 198;ILE A 179","None","1.06A","3ektB-4u0gA:undetectable","3ektB-4u0gA:19.39"],["3EL4_A_ROCA100_2","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;ILE A 199;THR A 183","None","1.16A","3el4B-4u0gA:undetectable","3el4B-4u0gA:18.05"],["3EM3_B_478B200_2","PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;ASP A 175;VAL A 178;GLY A 198;ILE A 179","None","0.98A","3em3B-4u0gA:undetectable","3em3B-4u0gA:18.32"],["3OXV_C_478C200_2","HIV-1 PROTEASE;HIV-1 PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;ASP A 175;VAL A 178;GLY A 198;ILE A 179","None","0.96A","3oxvD-4u0gA:undetectable","3oxvD-4u0gA:18.04"],["3OXW_B_017B200_2","HIV-1 PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;ASP A 175;VAL A 178;GLY A 198;ILE A 179","None","0.98A","3oxwB-4u0gA:undetectable","3oxwB-4u0gA:19.07"],["3OXW_D_017D200_2","HIV-1 PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;ASP A 175;VAL A 178;GLY A 198;ILE A 179","None","1.02A","3oxwD-4u0gA:undetectable","3oxwD-4u0gA:19.07"],["4DQC_A_017A101_1","ASPARTYL PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;ASP A 175;VAL A 178;GLY A 198;ILE A 179","None","1.03A","4dqcA-4u0gA:undetectable","4dqcA-4u0gA:18.72"],["4E1G_A_LNLA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1","Mycobacterium tuberculosis",5,"ILE H  40;GLY H 100;ALA H  96;SER H  66;GLY H  33","None","0.95A","4e1gA-4u0gH:undetectable","4e1gA-4u0gH:15.49"],["4GBO_A_CUA301_0","E7","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"HIS A 171;ALA A 117;GLN A  94;TYR A  90","None","1.19A","4gboA-4u0gA:undetectable","4gboA-4u0gA:22.13"],["4MBS_B_MRVB1101_2","CHIMERA PROTEIN OF C-C CHEMOKINE RECEPTOR TYPE 5 AND RUBREDOXIN","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"TYR A 206;LEU A 189;THR A 202;MET A 125","None","1.49A","4mbsB-4u0gA:undetectable","4mbsB-4u0gA:18.81"],["4NJT_B_017B101_1","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;THR A 183;ILE A 179","None","0.99A","4njtA-4u0gA:undetectable","4njtA-4u0gA:17.77"],["4NJT_D_017D101_1","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;THR A 183;ILE A 179","None","0.88A","4njtC-4u0gA:undetectable","4njtC-4u0gA:17.77"],["4NJU_A_TPVA500_2","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;ILE A 199;ILE A 179","None","1.08A","4njuB-4u0gA:undetectable","4njuB-4u0gA:17.77"],["4NJU_A_TPVA500_2","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;THR A 183;ILE A 179","None","1.05A","4njuB-4u0gA:undetectable","4njuB-4u0gA:17.77"],["4NJU_C_TPVC500_2","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;ILE A 199;ILE A 179","None","1.07A","4njuD-4u0gA:undetectable","4njuD-4u0gA:17.77"],["4NJU_C_TPVC500_2","PROTEASE;PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;THR A 183;ILE A 179","None","1.05A","4njuD-4u0gA:undetectable","4njuD-4u0gA:17.77"],["4O1Z_B_MXMB807_1","PROSTAGLANDIN G\/H SYNTHASE 1","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"MET A  93;LEU A  60;LEU A 115;ALA A  53;SER A  52","None","0.91A","4o1zB-4u0gA:undetectable","4o1zB-4u0gA:16.95"],["4QWP_A_GCSA303_1","CHITOSANASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1","Mycobacterium tuberculosis",4,"GLU H 101;TYR H 183;ILE H 165;THR H 158","None","0.92A","4qwpA-4u0gH:undetectable","4qwpA-4u0gH:23.72"],["4QWP_B_GCSB302_1","CHITOSANASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1","Mycobacterium tuberculosis",4,"GLU H 101;TYR H 183;ILE H 165;THR H 158","None","0.88A","4qwpB-4u0gH:undetectable","4qwpB-4u0gH:23.72"],["4RVJ_B_478B101_1","HIV-1 PROTEASE;HIV-1 PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;THR A 183;ILE A 179","None","0.97A","4rvjA-4u0gA:undetectable","4rvjA-4u0gA:17.77"],["4RVJ_D_478D101_1","HIV-1 PROTEASE;HIV-1 PROTEASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"ALA A 169;VAL A 178;GLY A 198;THR A 183;ILE A 179","None","0.96A","4rvjC-4u0gA:undetectable","4rvjC-4u0gA:17.77"],["4XJ7_D_ADND303_1","5'\/3'-NUCLEOTIDASE SURE;5'\/3'-NUCLEOTIDASE SURE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1","Mycobacterium tuberculosis",5,"LEU H 103;LEU H  32;GLY H 100;SER H  98;ALA H  76","None;None;None;ZIL H 301 ( 2.9A);None","1.12A","4xj7C-4u0gH:undetectable;4xj7D-4u0gH:undetectable","4xj7C-4u0gH:24.07;4xj7D-4u0gH:24.07"],["5BTA_G_MFXG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"ARG A 180;GLY A 177;THR A 162;GLU A 165","SO4 A 302 (-4.6A);None;None;None","0.99A","5btaA-4u0gA:undetectable;5btaC-4u0gA:undetectable;5btaD-4u0gA:undetectable","5btaA-4u0gA:19.78;5btaC-4u0gA:19.78;5btaD-4u0gA:23.37"],["5BTA_H_MFXH101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCACGTAA","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"ARG A 180;GLY A 177;THR A 162;GLU A 165","SO4 A 302 (-4.6A);None;None;None","0.96A","5btaA-4u0gA:undetectable;5btaB-4u0gA:undetectable;5btaC-4u0gA:undetectable","5btaA-4u0gA:19.78;5btaB-4u0gA:23.37;5btaC-4u0gA:19.78"],["5BTC_G_CPFG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"ARG A 180;GLY A 177;THR A 162;GLU A 165","SO4 A 302 (-4.6A);None;None;None","1.01A","5btcA-4u0gA:undetectable;5btcC-4u0gA:undetectable;5btcD-4u0gA:undetectable","5btcA-4u0gA:19.78;5btcC-4u0gA:19.78;5btcD-4u0gA:23.37"],["5BTC_G_CPFG102_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"ARG A 180;GLY A 177;THR A 162;GLU A 165","SO4 A 302 (-4.6A);None;None;None","0.97A","5btcA-4u0gA:undetectable;5btcB-4u0gA:undetectable;5btcC-4u0gA:undetectable","5btcA-4u0gA:19.78;5btcB-4u0gA:23.37;5btcC-4u0gA:19.78"],["5BTF_F_GFNF101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"ARG A 180;GLY A 177;THR A 162;GLU A 165","SO4 A 302 (-4.6A);None;None;None","0.97A","5btfA-4u0gA:undetectable;5btfB-4u0gA:undetectable;5btfC-4u0gA:undetectable","5btfA-4u0gA:19.78;5btfB-4u0gA:23.37;5btfC-4u0gA:19.78"],["5DZK_O_BEZO801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"PHE A  83;SER A 110;HIS A 135;PRO A 137;MET A 164","ZIL A 301 (-4.5A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 (-3.8A);ZIL A 301 ( 2.9A)","0.49A","5dzka-4u0gA:27.3;5dzko-4u0gA:undetectable","5dzka-4u0gA:100.00;5dzko-4u0gA:1.92"],["5DZK_P_BEZP801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"SER A 110;ALA A 111;HIS A 135;MET A 164","ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 ( 2.9A)","0.41A","5dzkb-4u0gA:27.7;5dzkp-4u0gA:undetectable","5dzkb-4u0gA:100.00;5dzkp-4u0gA:1.92"],["5DZK_P_BEZP801_1","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"PHE A  83;SER A 110;ALA A 111;HIS A 135;MET A 164","ZIL A 301 (-4.5A);ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 ( 2.9A)","0.49A","5dzkB-4u0gA:27.7;5dzkP-4u0gA:undetectable","5dzkB-4u0gA:100.00;5dzkP-4u0gA:1.92"],["5DZK_Q_BEZQ801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"SER A 110;ALA A 111;HIS A 135;MET A 164","ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 ( 2.9A)","0.42A","5dzkc-4u0gA:27.3;5dzkq-4u0gA:undetectable","5dzkc-4u0gA:100.00;5dzkq-4u0gA:1.92"],["5DZK_R_BEZR801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",6,"PHE A  83;SER A 110;ALA A 111;HIS A 135;PRO A 137;MET A 164","ZIL A 301 (-4.5A);ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 (-3.8A);ZIL A 301 ( 2.9A)","0.47A","5dzkD-4u0gA:27.4;5dzkR-4u0gA:undetectable","5dzkD-4u0gA:100.00;5dzkR-4u0gA:1.92"],["5DZK_R_BEZR801_1","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",6,"PHE A  83;SER A 110;ALA A 111;HIS A 135;PRO A 137;MET A 164","ZIL A 301 (-4.5A);ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 (-3.8A);ZIL A 301 ( 2.9A)","0.47A","5dzkd-4u0gA:27.4;5dzkr-4u0gA:undetectable","5dzkd-4u0gA:100.00;5dzkr-4u0gA:1.92"],["5DZK_S_BEZS801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"PHE A  83;SER A 110;HIS A 135;MET A 164","ZIL A 301 (-4.5A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 ( 2.9A)","0.50A","5dzke-4u0gA:27.6;5dzks-4u0gA:undetectable","5dzke-4u0gA:100.00;5dzks-4u0gA:1.92"],["5DZK_T_BEZT801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"SER A 110;ALA A 111;HIS A 135;MET A 164","ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 ( 2.9A)","0.42A","5dzkf-4u0gA:27.4;5dzkt-4u0gA:undetectable","5dzkf-4u0gA:100.00;5dzkt-4u0gA:1.92"],["5DZK_T_BEZT801_1","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",6,"PHE A  83;SER A 110;ALA A 111;HIS A 135;PRO A 137;MET A 164","ZIL A 301 (-4.5A);ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 (-3.8A);ZIL A 301 ( 2.9A)","0.46A","5dzkF-4u0gA:27.4;5dzkT-4u0gA:undetectable","5dzkF-4u0gA:100.00;5dzkT-4u0gA:1.92"],["5DZK_U_BEZU801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",5,"PHE A  83;SER A 110;ALA A 111;HIS A 135;MET A 164","ZIL A 301 (-4.5A);ZIL A 301 ( 4.0A);ZIL A 301 ( 4.0A);ZIL A 301 (-3.7A);ZIL A 301 ( 2.9A)","0.49A","5dzkg-4u0gA:27.4;5dzku-4u0gA:undetectable","5dzkg-4u0gA:100.00;5dzku-4u0gA:1.92"],["5DZK_W_BEZW801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1","Mycobacterium tuberculosis;Mycobacterium tuberculosis",4,"PHE A 147;ILE H  71;GLY H 127;ILE H 146","ZIL H 301 ( 4.8A);ZIL H 301 (-3.6A);ZIL H 301 ( 3.5A);ZIL H 301 ( 3.3A)","0.38A","5dzkB-4u0gA:27.7;5dzkI-4u0gA:31.4;5dzkW-4u0gA:undetectable","5dzkB-4u0gA:100.00;5dzkI-4u0gA:41.58;5dzkW-4u0gA:1.92"],["5DZK_Y_BEZY801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1","Mycobacterium tuberculosis;Mycobacterium tuberculosis",4,"PHE A 147;ILE H  71;GLY H 127;ILE H 146","ZIL H 301 ( 4.8A);ZIL H 301 (-3.6A);ZIL H 301 ( 3.5A);ZIL H 301 ( 3.3A)","0.35A","5dzkd-4u0gA:27.4;5dzkk-4u0gA:31.4;5dzky-4u0gA:undetectable","5dzkd-4u0gA:100.00;5dzkk-4u0gA:41.58;5dzky-4u0gA:1.92"],["5M5K_A_ADNA502_2","ADENOSYLHOMOCYSTEINASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"GLN A 136;THR A 183;THR A 167;LEU A  86","None;None;None;ZIL A 301 ( 4.3A)","1.49A","5m5kA-4u0gA:undetectable","5m5kA-4u0gA:18.96"],["5M5K_C_ADNC502_2","ADENOSYLHOMOCYSTEINASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"GLN A 136;THR A 183;THR A 167;LEU A  86","None;None;None;ZIL A 301 ( 4.3A)","1.49A","5m5kC-4u0gA:undetectable","5m5kC-4u0gA:18.96"],["5M66_B_ADNB502_2","ADENOSYLHOMOCYSTEINASE","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"GLN A 136;THR A 183;THR A 167;LEU A  86","None;None;None;ZIL A 301 ( 4.3A)","1.46A","5m66B-4u0gA:undetectable","5m66B-4u0gA:18.96"],["5UIZ_A_CUA301_0","AA10A","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"HIS A 171;ALA A 117;GLN A  94;TYR A  90","None","1.21A","5uizA-4u0gA:undetectable","5uizA-4u0gA:22.13"],["6F3M_B_ADNB502_2","-","4u0g","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2","Mycobacterium tuberculosis",4,"GLN A 136;THR A 183;THR A 167;LEU A  86","None;None;None;ZIL A 301 ( 4.3A)","1.47A","6f3mB-4u0gA:undetectable","6f3mB-4u0gA:17.83"]]